Unlocking new possibilities
for millions with neurological disease

By developing our own proprietary neural exosome platform, Aruna Bio has succeeded in gaining access across the blood-brain barrier. Our therapeutic neural cell-derived exosome, AB126, demonstrates multiple modes of action:

This makes AB126 ideal for the treatment of acute neuro-conditions and chronic neurodegenerative diseases which could transform the lives of millions of people around the world.

View our corporate presentation